Eir Ventures, Vaekstfonde lead investment round in Synklino to help eliminate transplant-related infections

Eir Ventures and Vaekstfonde have led a seed financing round for Synklino, a biotech company developing a treatment to eliminate certain infections which can cause complications in transplants.